Analysis of serum lipids, cardiovascular risk and indication for statin therapy at the start and during imatinib and nilotinib therapy in de novo CML patients, results from real life prosective study

• Authors: HORŇÁK Tomáš; SEMERÁD Lukáš; ŽÁČKOVÁ Daniela; WEINBERGEROVÁ Barbora; ŠUSTKOVÁ Zuzana; PROCHÁZKOVÁ Jiřina; MAYER Jiří; RÁČIL Zdeněk
• Year of publication: 2018
• Type: Conference abstract